C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
167/139, 167/40
C12N 9/68 (2006.01) A61K 39/395 (2006.01) A61K 47/48 (2006.01) A61K 51/10 (2006.01) C07K 16/18 (2006.01) C07K 16/36 (2006.01) C07K 16/40 (2006.01) C12N 9/70 (2006.01) C12N 9/72 (2006.01) C12N 15/66 (2006.01) A61K 38/00 (2006.01)
Patent
CA 1339445
This invention relates to a recombinant hybrid immunoglobulin molecule having an antigen binding site specific for fibrin linked to a second protein comprising the active portion of a plasminogen activator. The invention is also directed to the cloning and production of these novel hybrid immunoglobulin molecules. This invention further relates to a method of using these recombinant hybrid immunoglobulin molecules in immunodiagnostic and immunotherapeutic processes.
551434
Haber Edgar
Quertermous Thomas
Gowling Lafleur Henderson Llp
The General Hospital Corporation
LandOfFree
Recombinant hybrid immunoglobulin molecules and method of use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Recombinant hybrid immunoglobulin molecules and method of use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant hybrid immunoglobulin molecules and method of use will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1266114